Pfizer and Novo Nordisk Engage in $10 Billion Battle for Metsera
TL;DR Summary
Pfizer has accepted a $10 billion bid to acquire Metsera, potentially ending a bidding war with Novo Nordisk over obesity drug assets, with the deal expected to close after Metsera's November 13 shareholder meeting.
- Metsera accepts Pfizer's $10 billion bid in ongoing M&A battle Reuters
- Pfizer and Metsera Reach Deal Expected to Top $10 Billion The Wall Street Journal
- Novo Nordisk CEO Challenges Pfizer to Raise its Bid for Metsera Bloomberg.com
- Pfizer matches Novo bid for obesity biotech Metsera as takeover battle rages Financial Times
- Pfizer and Novo Nordisk Face Off in $10 Billion Battle for Metsera Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
95%
709 → 34 words
Want the full story? Read the original article
Read on Reuters